COMMUNIQUÉS West-GlobeNewswire

EyePoint Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
31/01/2024
WATERTOWN, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal [...]
Tango Therapeutics to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference
31/01/2024
BOSTON, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Tango Therapeutics , Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today [...]
Tilray Beers: A Lock for the Big Game
31/01/2024
Tilray’s Fan-Favorite Breweries Have Big Game Beers for the Biggest Football Game of the Year NEW YORK, Jan. 31, 2024 (GLOBE NEWSWIRE) -- As football fans gear up for the biggest showdown of the year, Tilray Brands , (" [...]
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
31/01/2024
BOSTON, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced that management [...]
NC AMVETS Service Foundation Launches CBD Study for Veterans with University of Northern Colorado and Vantage Hemp Co.
31/01/2024
National research initiative will uncover insights into CBD efficacy and advocate for America’s veterans Rockwell, North Carolina, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The North Carolina AMVETS Service Foundation , a 501(c [...]
Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.
31/01/2024
-Repositioning to a rapidly expanding biosensor market with potential for significant growth for the company as part of a revised strategy under our new management -Upfront payment of $12.5 million cash and 9 million [...]
Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast to Treat CKD
31/01/2024
VANCOUVER, British Columbia, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) a Canadian clinical stage pharmaceutical development [...]
Tonix Pharmaceuticals Announces Research Indicating Pre-Existing Fibromyalgia-Type Symptoms May Increase the Risk of Developing Long COVID
31/01/2024
Retrospective observational study of electronic medical records of more than 90 million people living in the U.S. Long COVID shares symptoms with chronic overlapping pain disorders like fibromyalgia and appears [...]
Kymera Therapeutics to Present in Fireside Chat at the Guggenheim Healthcare Conference
31/01/2024
WATERTOWN, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein [...]
InspireMD Receives CE Mark Recertification Under EU’s New Medical Device Regulation (MDR) Regulatory Framework
31/01/2024
TEL AVIV, Israel and MIAMI, Jan. 31, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Carotid Stent System (EPS) for the prevention of stroke, today announced that it [...]
BioCardia Announces Two Scientific Abstracts Have Been Accepted at the 2024 Technology and Heart Failure Therapeutics Conference
31/01/2024
SUNNYVALE, Calif., Jan. 31, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. (“BioCardia” or the “Company”) (Nasdaq: BCDA), a biotechnology company focused on advancing late-stage cell therapy interventions for cardiovascular [...]
OKYO Pharma Announces Distinguished Ophthalmologists with Expertise in the Medical and Surgical Treatment of Ocular Surface Diseases Join its Scientific Advisory Board
31/01/2024
LONDON and NEW YORK, Jan. 31, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of inflammatory dry eye disease ( [...]
BioNTech and DualityBio Receive FDA Fast Track Designation for Next-Generation Antibody-Drug Conjugate Candidate BNT325/DB-1305
31/01/2024
Designation is based on preliminary safety and efficacy data from an ongoing Phase 1/2 trial in patients with platinum-resistant ovarian epithelial cancer, fallopian tube, or primary peritoneal cancer 1 Fast Track [...]
Zymeworks Announces Participation in Upcoming Investor Conferences
31/01/2024
VANCOUVER, British Columbia, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the [...]
Half-year report
31/01/2024
DXS INTERNATIONAL PLC (AQSE: DXSP) HALF YEAR RESULTS DXS International plc ("DXS" or the "Company"), the digital clinical decision support company, is pleased to provide shareholders with its unaudited interim results [...]
BioSenic provides support to forthcoming European conference on graft-versus-host disease
31/01/2024
Mont-Saint-Guibert, Belgium, January 31, 2024, 7.00 am CEST – BioSenic (Euronext Brussels and Paris: BIOS) , the clinical-stage company specializing in serious autoimmune and inflammatory diseases and cell therapy, [...]
BioSenic soutient la prochaine conférence européenne sur la maladie du greffon contre l'hôte
31/01/2024
Mont-Saint-Guibert, Belgique, le 31 janvier 2024, à 7h00 CEST – BIOSENIC ( Euronext Bruxelles et Paris : BIOS) , société spécialisée en essais cliniques dans les maladies auto-immunes et inflammatoires graves et la [...]
Release date of annual report 2023 for ALK and webcast
31/01/2024
On Thursday, 8 February 2024 in the afternoon, ALK ( ALKB:DC / OMX: ALK B / AKBLF ) releases its annual report for 2023. ALK will host an online meeting for analysts and institutional investors that day at 4.00pm (CET) [...]
Nexstim Plc: Proposals of the Shareholder’s Nomination Board to the Annual General Meeting
31/01/2024
Company announcement, Helsinki, 31 January 2024 at 10 AM (EET) Nexstim Plc: Proposals of the Shareholder’s Nomination Board to the Annual General Meeting The Shareholder’s Nomination Board of Nexstim Corporation (NXTMH: [...]

Pages